Latest News

Why Amprius Technologies Stock Is Getting Attention Amprius Technologies (AMPX) has been drawing fresh interest after a stretch of strong multi period returns and rapid reported growth in both revenue and net income, prompting investors to reassess expectations around this battery maker. See our latest analysis for Amprius Technologies. The current share price of US$14.89 comes after a sharp 18.65% 1 day share price return and a 29.25% 7 day share price return, adding to a strong year to date...

Why UroGen Pharma (URGN) is on investors’ radar today UroGen Pharma (URGN) has drawn fresh attention after recent trading saw the stock close at $20.16, with a 7.1% move over the past day and mixed returns over the past year. See our latest analysis for UroGen Pharma. The latest 1 day share price return of 7.1% at $20.16 comes after mixed short term moves, including a 30 day share price return of 2.3% and a 90 day share price decline of 17.0%. Meanwhile, the 1 year total shareholder return of...

In late February and early March 2026, SiTime participated in high-profile investor conferences hosted by Raymond James in Orlando and Morgan Stanley in San Francisco, where CEO Rajesh Vashist and CFO Elizabeth Howe addressed institutional investors. These appearances came shortly after heightened AI-focused sector commentary and SiTime’s acquisition of Renesas’ timing business, drawing extra attention to its exposure to AI data center infrastructure. Now we’ll examine how this increased...

If you are looking at First American Financial and wondering whether the current share price lines up with the underlying value, you are not alone. The stock last closed at US$69.03, with returns of 1.1% over 7 days, 6.7% over 30 days, 13.0% year to date, 11.7% over 1 year, 41.4% over 3 years and 40.3% over 5 years, which gives plenty of context for a closer look at pricing. Recent news around First American Financial has focused on ongoing interest in title insurance and related financial...

Why Quebecor’s latest earnings and dividend move matter for shareholders Quebecor (TSX:QBR.A) has put fresh numbers on the table, with fourth quarter and full year 2025 earnings, along with a higher quarterly dividend that together reshape how you might think about this telecom led group. See our latest analysis for Quebecor. Quebecor’s recent fourth quarter results, dividend increase and Freedom Mobile progress have arrived alongside firm share price momentum, with a 14.2% 1 month share...

Stock performance snapshot and recent returns Lionsgate Studios (LION) has caught investors' attention after a recent move in its share price. The stock closed at $9.43, with a 3.85% gain over the past day and 14.44% over the past week. Looking at slightly longer periods, the shares show a 2.17% return over the past month and 32.82% over the past 3 months. The 1 year total return stands at 18.31%, and the 3 year total return at 11.86%. See our latest analysis for Lionsgate Studios. The recent...

Verizon Communications (NYSE:VZ), Aptiv and Wind River have introduced a proof-of-concept connected-driving V2X platform. The solution uses Verizon's 5G network and edge compute capabilities to let vehicles share real-time sensor data. The platform is designed to support safety-related and cooperative driving features without requiring specialized in-vehicle hardware. For Verizon, this project sits at the intersection of its core 5G connectivity business and the broader push toward...

Conference appearance puts Doximity (DOCS) in focus for telehealth investors Doximity (DOCS) heads into its ViVE 2026 conference appearance in Los Angeles, with CEO Jeffrey Tangney presenting, keeping attention on how its digital tools and telemedicine platform might support the business. See our latest analysis for Doximity. Despite the upcoming ViVE appearance and interest in its telehealth tools, Doximity’s share price return has been weak over longer periods. It has a 30 day share price...

Why 3M (MMM) is back in focus after Q4 2025 3M (MMM) is drawing fresh attention after its Q4 2025 earnings showed a 20% year over year EPS drop tied to special items, including litigation and PFAS related charges. For investors, that combination of pressured earnings, underperformance versus the S&P 500, and continued Wall Street coverage raises practical questions about how to evaluate the stock today. See our latest analysis for 3M. At a latest share price of US$160.89, 3M’s 1 month share...

Volkswagen (XTRA:VOW3) is facing a new class-action lawsuit in the U.S. filed by a group of its franchised dealerships. The dealers allege the company breached existing agreements by using Scout Motors to sell electric vehicles directly to consumers. The case centers on whether Scout branded EVs should pass through the traditional dealer model or a separate direct to consumer channel. For you as an investor, this dispute sits at the intersection of legacy auto retail models and newer direct...

Yelp (YELP) put its product roadmap in the spotlight at the Morgan Stanley Technology, Media & Telecom Conference, outlining how AI, new partnerships and an acquisition could reshape its platform and advertising economics. See our latest analysis for Yelp. Yelp's recent focus on AI partnerships and the Hatch acquisition comes as the share price has seen short term momentum, with a 1 day share price return of 2.42% and 7 day return of 11.77%, compared with a 1 year total shareholder return...

POET Technologies previously entered securities purchase agreements with institutional investors for a registered direct offering of about US$150 million to fund corporate development, targeted acquisitions and expansion of its high-speed optical module and light-source initiatives, alongside rising short interest and increased institutional ownership. At the same time, unusually heavy call option activity and higher implied volatility highlighted how traders are positioning around the...

Grand City Properties FY 2025 earnings snapshot Grand City Properties (XTRA:GYC) has wrapped up FY 2025 with Q4 revenue of €149.9 million and basic EPS of €0.79, set against a trailing twelve month net income of €511.9 million and EPS of €2.67. Over the past year, the company has seen revenue move from €597.0 million to €601.5 million on a trailing basis, while EPS shifted from €1.14 to €2.67, alongside a net profit margin of 85.1% that is influenced by a €272.5 million one off gain...

Why Garmin Stock Is Back on Investors’ Radar Garmin (GRMN) has drawn fresh attention after a month in which the stock returned about 21%, extending a gain of roughly 24% over the past 3 months and modestly outpacing its 1 year total return. With the shares last closing at US$251.18 and year to date performance of about 24%, some investors are rechecking how this price lines up against Garmin’s recent financial profile, including revenue of US$7,245.519m and net income of US$1,663.887m. See...

Stock performance snapshot and recent moves Pulse Biosciences (PLSE) has recently drawn investor attention after a month return of 32% and a past 3 months return of 36.4%, with the shares last closing at US$18.10. Over a longer horizon, the stock shows a year to date return of 35.2% and a 1 year total return of 2.5%. The 3 year total return figure is very large at about 7x. At the same time, the 5 year total return sits at a 37.2% decline, giving investors a mixed performance picture that may...

Aardvark Therapeutics (AARD) has put its Phase 3 HERO trial for ARD-101 in Prader-Willi Syndrome on hold after reversible cardiac issues at higher doses, triggering delays, legal scrutiny, and sharp share price swings. See our latest analysis for Aardvark Therapeutics. The HERO trial pause has been the clear driver of volatility, with Aardvark Therapeutics’ 1-day share price return of 15.1% coming after sharp declines, including a 57.6% 30-day share price loss and a 50.4% 1-year total...

This article is intended to help you assess whether Hims & Hers Health at around US$16.45 still offers value or whether most of the opportunity is already reflected in the share price. The stock has returned 4.0% over the last 7 days, compared with a 30 day return of a 37.8% decline, a year to date return of a 50.8% decline and a 1 year return of a 59.8% decline, while the 3 year and 5 year returns stand at 66.5% and 24.4% respectively. These mixed returns have kept Hims & Hers Health on the...

Recent performance snapshot Thermo Fisher Scientific (TMO) has been on many investors’ radar after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months and year to date. At a last close of $512.69, the company shows a 1 day return of 0.9% and a 7 day return that is close to flat. Over the past month and past 3 months, returns are each in the low double digit decline range. Over a 1 year period, the total return sits in the low single...

StubHub Holdings (NYSE:STUB) has appointed Jack Sterne as Head of Policy Communications. The move comes as regulators and lawmakers increase scrutiny of ticket resale platforms. Key states are advancing bills that would cap ticket resale prices for consumers. The hire signals StubHub's focus on policy, regulatory and public affairs capabilities. StubHub operates a major ticket resale marketplace, positioned between event organizers, primary ticketing firms and secondary market sellers. With...

Green Thumb Industries (CNSX:GTII) is back in focus after reporting fourth quarter and full year 2025 results, along with softer first quarter 2026 revenue guidance tied to pricing pressure and seasonality. See our latest analysis for Green Thumb Industries. Despite the solid 2025 earnings, Green Thumb Industries’ share price return tells a more cautious story. The stock recorded a 1 day gain of 1.94% and a year to date share price return of 19.46%, while the 1 year total shareholder return...

Toronto-Dominion Bank (TSX:TD) just paired stronger quarterly earnings with fresh dividend declarations on both common and preferred shares, while outlining AI driven cost efficiencies that could reshape how investors think about its long term profitability profile. See our latest analysis for Toronto-Dominion Bank. At a share price of CA$134.7, Toronto-Dominion Bank has posted a 4.29% 30 day share price return and a 65.14% 1 year total shareholder return, signaling solid momentum as recent...

In February 2026, Dalrymple Bay Infrastructure Limited reported its full-year 2025 results, with revenue rising to A$849.81 million while net income fell to A$29.26 million, and simultaneously lifted its FY26 distribution guidance to 26.375 cents per security. The company also declared a higher quarterly distribution of A$0.0675 per security, signalling management’s confidence in the cash-generative strength of its regulated coal export terminal despite softer earnings. We’ll now examine how...

In February 2026, Mitsubishi Electric Corporation approved organizational and executive officer changes effective April 1, 2026, including consolidating culture reform into a newly renamed Corporate Human Resources & Culture Transformation Group. The reshaped leadership structure, including expanded technology, risk, and global planning roles, highlights Mitsubishi Electric's intention to align governance, human capital, and innovation with emerging growth areas such as smart building and...

General Mills (NYSE:GIS) has made its entire K-12 school foods portfolio free of certified colors. The company reached this milestone ahead of its previously announced summer 2026 target. The reformulation covers all products in its K-12 school foods line served in educational settings. For you as an investor, this move highlights how General Mills is positioning its K-12 foodservice business around clean-label and ingredient transparency themes that matter to schools, parents, and...